Article information
Full text is only aviable in PDF
Bibliografía
[1.]
Occupational exposure to diisocyanates NIOSH criteria document for a recommended standard. Publication 78-215. Washington. DC, US Department of Health, Education and Welfare.
[2.]
H. Ulrich.
Urethane polymers.
Kirk-Othmer: Encyclopedia of Chemical technology, John Wiley & Sons Inc, (1983), pp. 507-608
[4.]
R.J. Davies.
Respiratory hypersensitivity to diisocyanates.
Clin Immunol Allergy, 4 (1984), pp. 103-123
[5.]
ACGIH.
Documentation of the Threshold limit Value and biological exposure indices.
5 ed, Cincinnati, (1986),
[6.]
W.G.F. Adams.
Long-term effects on the health of men engaged in the manufacture of tolylene.
Br J Ind Med, 32 (1975), pp. 72-78
[7.]
J.M. Peters, R.L.H. Murphy, L.D. Pagnato, et al.
Acute respiratory effects in workers exposed to low levels of TDI.
Arch Environ Health, 16 (1986), pp. 642-647
[8.]
J.M. Peters.
Studies of isocyanate toxicity. Cumulative pulmonary effects in workers exposed to toluene diisocyanate.
Proc Roy Soc Med, 63 (1970), pp. 372-375
[9.]
D.H. Wegman, J.M. Peters, L. Pagnotto, et al.
Chronic pulmonary function loss from exposure to toluene diisocyanate.
Br J Industr Med, 34 (1977), pp. 196-200
[10.]
A.W. Musk, J.M. Peters, L. DiBernardis, et al.
Absence of respiratory effects in subjects exposed to low concentrations of TDI and MDI.
J Occup Med, 24 (1982), pp. 746-750
[11.]
J.B. Gee, W.K.C. Morgan.
A 10 year follow-up study of a group of workers exposed to isocyanates.
J Occup Med, 27 (1985), pp. 15-18
[12.]
J.E. Diem, R.N. Jones, D.J. Hendrick, et al.
Five year longitudinal study of workers employed in a new toluene diisocyanate manufactoring plant.
Am Rev Respir Dis, 126 (1982), pp. 420-428
[13.]
Q.T. Pham, C. Cavelier, P. Mereau, et al.
Isocyanate and respiratory function: a study of workers producing polyurethane foam moulding.
Ann Occup Hyg, 21 (1978), pp. 12-129
[14.]
S. Fuch, P. Valade.
Etude clinique et experimentale sur quelques cas d’intoxication par les Desmour T (diisocyanate de Toluene 1-2-4 et 1-2-6).
Arch Mal Prof Med Trav et Sec Soc, 12 (1951), pp. 191-196
[15.]
A.R. Tansar, M.P. Bourke, A.G. Blandford.
Isocyanate asthma: respiratory symptoms caused by disphenylmethane diisocianate.
Thorax, 28 (1973), pp. 596-600
[16.]
M. Zammit-Tabonga, M. Sherkin, K. Kijek, et al.
Asthma caused by diphenylmethane diisocyanate in foundry workers.
Am Rev Respir Dis, 128 (1983), pp. 226-230
[17.]
I.M. O’Brien, M.G. Harries, P.S. Burge, et al.
Toluene diisocianate-induced asthma. Reaction to TDI, MDI, HDI and histamine.
Clin Allergy, 9 (1979), pp. 1-6
[18.]
B.T. Butcher, R.N. Jones, C.E. O’Neil, et al.
Longuitudinal study of workers employed in the manufacture of toluene diisocyanate.
Am Rev Respir Dis, 116 (1977), pp. 411-421
[19.]
P. Gervais, N. Rosenberg.
Occupational respiratory allergy: Epidemiologic and medicolegal aspects. Proceeding XII International Congress of Allergology and Clinical Immunology.
Mosby Co, (1986), pp. 480-485
[20.]
J. Sastre, D.E. Banks, E. Ellis, et al.
Isocyanate-induced asthma: Review of 62 challenge tests.
Am Rev Respir Dis, 135 (1987), pp. 256
[21.]
D.R. Moller, R.T. McKay, I.L. Bernstein, et al.
Long-term followup of workers with TDI asthma.
Am Rev Respir Dis, (1984), pp. A159
[22.]
P.L. Paggiaro, A.M. Loi, O. Rossi, et al.
Follow-up study of patients with respiratory disease due to toluene diisocyanate (TDI).
Clin Allergy, 14 (1984), pp. 462-469
[23.]
J. Sastre, M.D. Ibañez.
Asma ocupacional por sustancias de bajo peso molecular.
Rev Esp Alergol Inmunol Clin, 2 (1987), pp. 391-400
[24.]
Stankus R, Sastre J, Salvaggio JE. Asthma induced by exposure to low molecular weight compounds and cigarette smoke. Current Pulmonol 1988 (en prensa).
[25.]
M. Chang-Yeung.
Occupational asthma.
Am Rev Respir Dis, 134 (1987), pp. 686-703
[26.]
M. Chang-Yeung.
Fate of occupational asthma: a follow-up study of patients with occupational asthma due to western red cedar (Thuja plicata).
Am Rev Respir Dis, 116 (1977), pp. 1.023-1.030
[27.]
R.J. Davies, B.T. Butcher, C.E. O’Neil, et al.
The in vitro effect of toluene diisocyanate on lymphocyte cyclic adenosine monophosphate production by isoproterenol, prostaglandin, and histamine.
J Allergy Clin Immunol, 60 (1977), pp. 223-229
[28.]
I.L. Berstein.
Isocyanate-induced pulmonary diseases: a current perspective.
J Allergy Clin Immunol, 70 (1982), pp. 24-31
[29.]
M.H. Karol, T. Sanderg, J. Riley, et al.
Longitudinal study of tolyl-reactive IgE antibodies in workers hypersensitivity to TDI.
J Occup Med, 21 (1979), pp. 354-358
[30.]
J.S. Gallager, C.S.T. Tse, S.M. Brooks, I.L. Berstein.
Diverse profile of immunoreactivity in toluene diisocyanate asthma.
J Occup Med, 23 (1981), pp. 610-613
[31.]
V. Baur, G. Fruhmann.
Specific IgE antibodies in patients with isocyanate asthma.
Chest, 80 (1981), pp. 73
[32.]
J.M. Danks, O. Cromwell, J.A. Buckingham, A.J. Newman-Taylor, R.J. Davies.
Toluene diisocyanate induced asthma: evaluation of antibodies in the serum of affected workers againts a tolyl monoisocyanate protein conjugate.
Clin Allergy, 11 (1981), pp. 161-164
[33.]
B.T. Butcher, C.E. O’Neil, M.A. Reed, et al.
Radioallergosorbent testing of toluene diisocyanate-reactive individuals using p-tolyl isocyanate antigen.
J Allergy Clin Immunol, 66 (1980), pp. 213-216
[34.]
B.T. Butcher, C. Mapp, M.A. Reed, et al.
Evidence for carrier specificity of IgE antibodies detected by isocyanate protein conjugate in sera of isocyanate sensitivity individuals.
J Allergy Clin Immunol, 69 (1982), pp. 123
[35.]
B.T. Butcher, R.N. Karr, C.E. O’Neil, et al.
Inhalation challenge and pharmacologic studies of toluene diisocianate-sensitive workers.
J Allergy Clin Immunol, 64 (1979), pp. 146-152
[36.]
J. Charles, A. Berstein, B. Jones, et al.
Hypersensitivity pneumonitis after exposures to isocyanates.
Thorax, 31 (1976), pp. 127-131
[37.]
J. Sastre, H.W. Barkman, M. López, D.E. Banks, J.E. Salvaggio.
Serum neutrophil chemotactic activity of high molecular weight in. toluene diisocyante induced asthma.
Am Rev Respir Dis, 56 (1987), pp. 1352
[38.]
B.R.C. O’Briscol, Th. Lee, O. Cromwell, A.B. Kay.
Immunologic release of neutrophil chemotactic activity from lung tissue.
J Allergy Clin Immunol, 72 (1983), pp. 695-701
[39.]
C. Mapp, G.R. DiGiacomo, L. Zedda, et al.
Isocyanate-induced asthma: Review of 165 cases studied in 1983-85.
J Allergy Clin Immunol, 77 (1986), pp. 173
[40.]
Y.Y. Hammad, R.J. Rando, H. Abdel-Kader.
Considerations in the design and use of human inhalation challenge delivery Systems.
Folia Allergol Immunol Clin, 32 (1985), pp. 37-44
[41.]
D.E. Banks, B.T. Butcher, J.E. Salvaggio.
Isocyanate-induced respiratory disease.
Ann Allergy, 57 (1987), pp. 389-396
[42.]
L.M. Fabbri, P. Chiesura-Corona, L. DelVecchio, et al.
Prednisone inhibits late asthmatic reaction and associated increase in airways responsiveness induced by TDI sensitized subjects.
Am Rev Respir Dis, 132 (1985), pp. 1.010-1.014
Copyright © 1988. Sociedad Española de Neumología y Cirugía Torácica
